Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma

BACKGROUND: Recently, maintaining higher relative dose intensity (RDI) of chemotherapeutic drugs has become a widespread practice in an attempt to achieve better outcomes in the treatment of aggressive lymphoma. The addition of rituximab to chemotherapy regimens has significantly improved outcome in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Terada, Yoshiki, Nakamae, Hirohisa, Aimoto, Ran, Kanashima, Hiroshi, Sakamoto, Erina, Aimoto, Mizuki, Inoue, Eri, Koh, Hideo, Nakane, Takahiko, Takeoka, Yasunobu, Ohsawa, Masahiko, Koh, Ki-Ryang, Yamane, Takahisa, Nakao, Yoshitaka, Ohta, Kensuke, Mugitani, Atsuko, Teshima, Hirofumi, Hino, Masayuki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2009
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2743657/
https://ncbi.nlm.nih.gov/pubmed/19689822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-28-116
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak